Skin autoimmunity and blood coagulation

References

• Opal SM. Phylogenetic and functional relationships between coagulation and the innate immune response. Crit Care Med. 2000; 28(Suppl):S77–S80.
   Google Scholar
• Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med. 2005; 15:254–259.
   PubMed Web of Science ®Google Scholar
• Esmon CT. Crosstalk between inflammation and thrombosis. Maturitas. 2008; 61:122–131.
   PubMed Web of Science ®Google Scholar
• Chu AJ. Tissue factor mediates inflammation. Arch Biochem Biophys. 2005; 440:123–132.
   PubMed Web of Science ®Google Scholar
• Dhar J, Andersen J, Essenmacher L, Ager J, Bentley G, Sokol R. Thrombophilic patterns of coagulation factors in lupus. Lupus. 2009; 18:400–406.
   PubMed Web of Science ®Google Scholar
• Ingegnoli F, Fantini F, Favalli EG, Soldi A, Griffini S, Galbiati V, Meroni PL, Cugno M. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: Effects of tumor necrosis factor-alpha blockade. J Autoimmun.. 2008; 31:175–179.
   PubMed Web of Science ®Google Scholar
• Borensztajn K, Peppelenbosch MP, Spek CA. Coagulation factor Xa signaling: The link between coagulation and inflammatory bowel disease?. Trends Pharmacol Sci. 2009; 30:8–16.
   PubMed Web of Science ®Google Scholar
• Greaves MW, Tan KT. Chronic urticaria: Recent advances. Clin Rev Allergy Immunol. 2007; 33:134–143.
   PubMed Web of Science ®Google Scholar
• O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997; 136:197–201.
   PubMed Web of Science ®Google Scholar
• Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW. A serological mediator in chronic idiopathic urticaria: A clinical, immunological and histological evaluation. Br J Dermatol. 1986; 114:583–590.
   PubMed Web of Science ®Google Scholar
• Hide M, Francis DM, Grattan CEH, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993; 328:1599–1604.
   PubMed Web of Science ®Google Scholar
• Soundararajan S, Kikuchi Y, Joseph K, . Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol. 2005; 115:815–821.
   PubMed Web of Science ®Google Scholar
• Pachlopnik JM, Horn MP, Fux M, Dahinden M, Mandallaz M, Schneeberger D, Baldi L, Vogel M, Stadler BM, Miescher SM. Natural anti-FcεRIα autoantibodies may interfere with diagnostic tests for autoimmune urticaria. J Autoimmun. 2004; 22:43–51.
   PubMedGoogle Scholar
• Puccetti A, Bason C, Simeoni S, Millo E, Tinazzi E, Beri R, . In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy. 2005; 35:1599–1607.
   PubMed Web of Science ®Google Scholar
• Rottem M. Chronic urticaria and autoimmune thyroid disease: Is there a link?. Autoimmun Rev. 2003; 2:69–72.
   PubMed Web of Science ®Google Scholar
• Baram D, Vaday GG, Salamon P, Drucker I, Hershkovicz R, Mekori YA. Human mast cells release metalloproteinase-9 on contact with activated T cells: Juxtacrine regulation by TNF-alpha. J Immunol. 2001; 167:4008–4016.
   PubMed Web of Science ®Google Scholar
• Gruber BL, Baeza ML, Marchese MJ, Agnello V, Kaplan AP. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988; 90:213–217.
   PubMed Web of Science ®Google Scholar
• Asero R, Riboldi P, Tedeschi A, Cugno M, Meroni P. Chronic urticaria: A disease at a crossroad between autoimmunity and coagulation. Autoimmun Rev.. 2007; 7:71–76.
   PubMed Web of Science ®Google Scholar
• Asero R, Tedeschi A, Riboldi P, Griffini S, Bonanni E, Cugno M. Severe chronic urticaria is associated with elevated plasma levels of d-dimer. Allergy. 2008; 63:176–180.
   PubMed Web of Science ®Google Scholar
• Cugno M, Marzano AV, Tedeschi A, Fanoni D, Venegoni L, Asero R. Expression of tissue factor by eosinophils in patients with chronic urticaria. Int Arch Allergy Immunol. 2009; 148:170–174.
   PubMed Web of Science ®Google Scholar
• Moosbauer C, Morgenstern E, Cuvelier SL, Manukyan D, Bidzhekov K, Albrecht S, Lohse P, Patel KD, Engelmann B. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood. 2007; 109:995–1002.
   PubMed Web of Science ®Google Scholar
• Cirino G, Cicala C, Bucci MR, Sorrentino L, Maranganore JM, Stone SR. Thrombin functions as an inflammatory mediator through activation of its receptors. J Exp Med. 1996; 183:821–827.
   PubMed Web of Science ®Google Scholar
• Nobe K, Sone T, Paul RJ, Honda K. Thrombin-induced force development in vascular endothelial cells: Contribution to alteration of permeability mediated by calcium-dependent and -independent pathways. J Pharmacol Sci. 2005; 99:252–263.
   PubMed Web of Science ®Google Scholar
• Vliagoftis H. Thrombin induces mast cell adhesion to fibronectin: Evidence for the involvement of protease-activated receptor-1. J Immunol. 2002; 169:4551–4558.
   PubMed Web of Science ®Google Scholar
• Wang F, Tang H, Xu J, Kang K. Activation of the blood coagulation cascade is involved in patients with chronic urticaria. J Allergy Clin Immunol. 2009; 123:972–973.
   PubMed Web of Science ®Google Scholar
• Khalaf AT, Liu XM, Sheng WX, Tan JQ, Abdalla AN. Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria. J Eur Acad Dermatol Venereol. 2008; 22:487–492.
   PubMed Web of Science ®Google Scholar
• Fujii K, Usuki A, Kan-No Y, Ohgou N. Elevation of circulating thrombin–antithrombin III complex and fibrin degradation products in urticaria. A laboratory finding unrelated to intravascular coagulopathy. J Dermatol. 2008; 35:308–310.
   PubMed Web of Science ®Google Scholar
• Yancey KB. The pathophysiology of autoimmune blistering diseases. J Clin Invest. 2005; 115:825–828.
   PubMed Web of Science ®Google Scholar
• Oostingh GJ, Sitaru C, Kromminga A, Dormann D, Zillikens D. Autoreactive T cell responses in pemphigus and pemphigoid. Autoimmun Rev. 2002; 1:267–272.
   Google Scholar
• Ameglio F, D'Auria L, Bonifati C, Ferraro C, Mastroianni A, Giacalone B. Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: Relationships with disease intensity. Br J Dermatol. 1998; 138:611–614.
   PubMed Web of Science ®Google Scholar
• Borrego L, Maynard B, Peterson EA, George T, Iglesias L, Peters MS, Newman W, Gleich GJ, Leiferman KM. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am J Pathol. 1996; 148:897–909.
   PubMed Web of Science ®Google Scholar
• Frezzolini A, Cianchini G, Ruffelli M, Cadoni S, Puddu P, De Pita O. Interleukin-16 expression and release in bullous pemphigoid. Clin Exp Immunol. 2004; 137:595–600.
   PubMed Web of Science ®Google Scholar
• Ståhle-Bäckdahl M, Inoue M, Guidice GJ, Parks WC. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest. 1994; 93:2022–2030.
   PubMed Web of Science ®Google Scholar
• Marzano AV, Tedeschi A, Fanoni D, Bonanni E, Venegoni L, Berti E, Cugno M. Activation of blood coagulation in bullous pemphigoid: Role of eosinophils, and local and systemic implications. Br J Dermatol. 2009; 160:266–272.
   PubMed Web of Science ®Google Scholar
• DeMichele MA, Moon DG, Fenton JWII, Minnear FL. Thrombin's enzymatic activity increases permeability of endothelial cell monolayers. J Appl Physiol. 1990; 69:1599–1606.
   PubMed Web of Science ®Google Scholar
• Rosendaal FR, Van Hylckama Vlieg A, Doggen CJM. Venous thrombosis in the elderly. J Thromb Haemost. 2007; 5 Suppl. 1: 310–317.
   Google Scholar
• Marzano AV, Tedeschi A, Spinelli D, Fanoni D, Crosti C, Cugno M. Coagulation activation in autoimmune bullous diseases. Clin Exp Immunol. 2009; 158:31–36.
   Google Scholar
• Meyer-De Schmid JJ, Neuman A. Treatment of chronic urticaria with heparin. Bull Soc Fr Dermatol Syphiligr. 1952; 59:286–287.
   PubMedGoogle Scholar
• Chua SL, Gibbs S. Chronic urticaria responding to subcutaneous heparin sodium. Br J Dermatol. 2005; 153:216–217.
   PubMed Web of Science ®Google Scholar
• Parslew R, Pryce D, Ashworth J, Friedmann PS. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy. 2000; 30:1161–1165.
   PubMed Web of Science ®Google Scholar
• Joly P, Benichou J, Lok C, Hellot MF, Saiag P, Tancrede-Bohin E, Sassolas B, Labeille B, Doutre MS, Gorin I, Pauwels C, Chosidow O, Caux F, Esteve E, Dutronc Y, Sigal M, Prost C, Maillard H, Guillaume JC, Roujeau JC. Prediction of survival for patients with bullous pemphigoid: A prospective study. Arch Dermatol. 2005; 141:691–698.
   PubMedGoogle Scholar